About Us

Back
Top > About Us > Message from the Dean

Message from the Dean

Greeting from the Dean of the School of Medicine/Graduate School of Medicine

門松研究科長On behalf of the Nagoya University School of Medicine and Graduate School of Medicine,
I am honored to have this opportunity to say a few words of greeting.

Nagoya University is one of the oldest universities in Japan, with 150 years of history and tradition since its founding as a temporary medical school and hospital for the Nagoya Domain in 1871 (Year 4 of the Meiji Period). In 1939, Nagoya University became Japan’s 7th Imperial University, consisting of a faculty of medicine and a faculty of science and engineering, and in 1949, after the Second World War, it made a new start as Nagoya University under the new education system.

In 1997, the Department of Health Sciences was established in the School of Medicine, bringing 2 faculties - Medicine and Health Sciences - under the umbrella of the School of Medicine. Both faculties are working on manpower training to contribute to modern medicine, especially with the focus on training the medical intern and medical personnel specialists, and bringing up its international leadership is one of our goals. In order to do so, the Department of Medicine launched the medical science café and student study group, and established the program for fundamental medical research for a half year in year 3 and overseas clinical clerkship in year 6. Furthermore, we lay emphasis on acquiring study-oriented students by setting an examination for selected candidates from high school presidents, bachelor transfer admission, and MDPhD course.

The graduate school in the School of Medicine is run by both the Department of Medicine and the Department of Health. The Department of Medicine runs the Comprehensive Medical science, and the International Program in Comprehensive Medical Science which implements the Joint Degree Programs with the University of Adelaide and Lund University.

The Comprehensive Medical science consists of 3 divisions: Basic Medicine, Clinical Medicine, and Clinical Pharmacology, and is trying to forward a unique action to let the culture of the pharmacy grow in the medical area. Additionally, university- industry research collaborations are moving forward by Industry-Academia Collaborative Chair and endowed chairs.
Oncology and Neurology research has been conducted by three COEs (COE, 21st Century COE, Global COE) and it has been the center of our education. A Physicians-led clinical trial for intractable neurological diseases has been conducted, and translational research has been in our focus as well. We will emphasize our strengths and aim for cutting edge research and education.

In 2015, the International Collaborative Program in Comprehensive Medical Science Program between Nagoya University and the University of Adelaide, Australia, the first of its kind, was established. Additionally, the joint degree PhD program with Lund University is added in 2017. In these programs, students will conduct their own reach project at the partner university for at least one year. Nagoya University and the partner university will grant a single jointly PhD diploma. Prestigious universities assure their high level of academic degree and this contributes to our university’s internationalization. Our pioneer approach started to expand its trends within Japan.

Moreover, in 2002, the Department of Health Science established a doctoral program in Nursing, Radiological and Medical Laboratory Sciences, and Physical and Occupational Therapy.These courses promote international medical training.

Our educational activities are supported by all the nations. For example, in July , 2014, the Medical Research Building 3 was built with the help of donations and tax. The educational environment for Morphology including Anatomy and Pathology got fulfilled and it also operates as a research facility which consolidates the Analytical Instruments Divisions. We receive expectations and a number of encouragements to our academic outcomes. To meet both their financial and spiritual support, our mission is to foster excellent human resource who contributes to international medicine and to return our research outcome to society. We ask you to lend us your strong support.

April 2017
Dean of the School of Medicine and Graduate School of Medicine
Kenji Kadomatsu

PROFILE M. 2017

Profile

KADOMATSU, Kenji
Graduate School of Medicine Program in Integrated Medicine

Specialty

Molecular Biology

Main Thesis
  1. Sato Y, Sato W, Maruyama S, Wilcox CS, Falck JR, Masuda T, Kosugi T, Kojima H, Maeda K, Furuhashi K, Ando M, Imai E, Matsuo S, Kadomatsu K. Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids. J Am Soc Nephrol. 26(8):1806-15 (2015).
  2. Kishida S, Mu P, Miyakawa S, Fujiwara M, Abe T, Sakamoto K, Onishi A, Nakamura Y, Kadomatsu K. Midkine Promotes Neuroblastoma through Notch2 Signaling. Cancer Res. 73(4):1318-27 (2013).
  3. Huang, P., Kishida, S., Cao, D., Murakami-Tonami, Y., Mu, P., Nakaguro, M., Koide, N., Takeuchi, I., Akina Onishi, A., Kadomatsu, K. The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma. Cancer Res. 71(8):2938-2948 (2011)
  4. Imagama S, Sakamoto K, Tauchi R, Shinjo R, Ohgomori T, Ito Z, Zhang H, Nishida Y, Asami N, Takeshita S, Sugiura N, Watanabe H, Yamashita T, Ishiguro N, Matsuyama Y, Kadomatsu K. Keratan sulfate restricts neural plasticity after spinal cord injury. J Neurosci. 31(47):17091-102 (2011)
  5. Ito Z, Sakamoto K, Imagama S, Matsuyama Y, Zhang H, Hirano K, Ando K, Yamashita T, Ishiguro N, Kadomatsu K. N-acetylglucosamine 6-O-sulfotransferase-1-deficient Mice Show Better Functional Recovery after Spinal Cord Injury. J. Neurosci. 30(17):5937-47 (2010).
  6. Kato N, Yuzawa Y, Kosugi T, Hobo A, Sato W, Miwa Y, Sakamoto K, Matsuo S, Kadomatsu K. The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J Am Soc Nephrol. 20(7):1565-76 (2009).
  7. Hobo A, Yuzawa Y, Kosugi T, Kato N, Asai N, Sato W, Maruyama S, Ito Y, Kobori H, Ikematsu S, Nishiyama A, Matsuo S, Kadomatsu, K. The growth factor midkine regulates the renin-angiotensin system in mice. J. Clin. Invest. 119(6):1616-1625 (2009).
  8. Kadomatsu K, Huang RP, Suganuma T, Murata F, Muramatsu T. A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol. 110(3):607-16 (1990).